The United States respects the Egypt’s involvement in the IPR sphere, but remains concerned about IPR challenges that hinder the IPR system improvement in Egypt. These include the failure to obtain deterrent-level sentences for IPR violations that are prosecuted and the need for additional training for enforcement officials, the need of specific regulations to clarify border procedures for the destruction of counterfeit and pirated products.
The United States advises Egypt to work also on clarifying its protection against the unfair commercial use of pharmaceutical products and the market access obstacles that have been reported recently by rights holders.
The entire report can be found here.
